Over the recent years the median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials. A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) iJournal of Thoracic Oncology/i, investigated the degree to which exclusion or underrepresentation of ...Saturday, 23 February 2013
In Phase III Trials Greater Representation of Elderly Patients are Needed
Over the recent years the median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials. A recent study published in the March 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) iJournal of Thoracic Oncology/i, investigated the degree to which exclusion or underrepresentation of ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment